Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21301335rdf:typepubmed:Citationlld:pubmed
pubmed-article:21301335lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:21301335lifeskim:mentionsumls-concept:C0023779lld:lifeskim
pubmed-article:21301335lifeskim:mentionsumls-concept:C0002679lld:lifeskim
pubmed-article:21301335lifeskim:mentionsumls-concept:C0008300lld:lifeskim
pubmed-article:21301335lifeskim:mentionsumls-concept:C0086123lld:lifeskim
pubmed-article:21301335lifeskim:mentionsumls-concept:C1708063lld:lifeskim
pubmed-article:21301335lifeskim:mentionsumls-concept:C0524527lld:lifeskim
pubmed-article:21301335pubmed:issue2lld:pubmed
pubmed-article:21301335pubmed:dateCreated2011-2-24lld:pubmed
pubmed-article:21301335pubmed:abstractTextThe aim is to compare the available evidence on the efficacy and safety of deoxycholate and lipid amphotericin B formulations (AMBF) in the treatment of invasive fungal disease (IFD) in neonates. The review also aims to summarize current practices and recommendations.lld:pubmed
pubmed-article:21301335pubmed:languageenglld:pubmed
pubmed-article:21301335pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21301335pubmed:citationSubsetIMlld:pubmed
pubmed-article:21301335pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21301335pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21301335pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21301335pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21301335pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21301335pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21301335pubmed:statusMEDLINElld:pubmed
pubmed-article:21301335pubmed:monthAprlld:pubmed
pubmed-article:21301335pubmed:issn1535-3877lld:pubmed
pubmed-article:21301335pubmed:authorpubmed-author:RoilidesEmman...lld:pubmed
pubmed-article:21301335pubmed:authorpubmed-author:SharlandMikeMlld:pubmed
pubmed-article:21301335pubmed:authorpubmed-author:TurkovaAnnaAlld:pubmed
pubmed-article:21301335pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21301335pubmed:volume24lld:pubmed
pubmed-article:21301335pubmed:ownerNLMlld:pubmed
pubmed-article:21301335pubmed:authorsCompleteYlld:pubmed
pubmed-article:21301335pubmed:pagination163-71lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:meshHeadingpubmed-meshheading:21301335...lld:pubmed
pubmed-article:21301335pubmed:year2011lld:pubmed
pubmed-article:21301335pubmed:articleTitleAmphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice?lld:pubmed
pubmed-article:21301335pubmed:affiliationPaediatric Infectious Diseases Unit, St George's Hospital, London, UK.lld:pubmed
pubmed-article:21301335pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21301335pubmed:publicationTypeReviewlld:pubmed